RecruitingNCT07014618

Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Impact of Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

Sponsor

University of Oklahoma

Enrollment

420 participants

Start Date

Oct 16, 2025

Study Type

OBSERVATIONAL

Conditions

Breast Cancer Prostate Cancer

Summary

The purpose of this clinical trial is to evaluate radiation therapy (RT) completion rates among underrepresented cancer populations using qualitative measurements. Additionally, the study aims to assess the impact of patient navigators on supporting patients through their radiation care, as well as their influence on adherence to standard of care treatment modalities.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

Subjects must have histologically or cytologically confirmed Breast or Prostate Cancer.
Subjects must be 18 years of age or older. This study requires informed consent by the subject.
Subjects must be of African American race, Native American race, or Hispanic ethnicity.
Subjects scheduled to undergo RT for Cancer Treatment.
Subjects must have the ability to understand and the willingness to sign a written informed consent document.

Exclusion Criteria3

Subjects NOT of African American race, Native American race or Hispanic ethnicity.
Subjects WITHOUT histologically/cytologically confirmed Breast or Prostate Cancer.
Subjects younger than 18 years old.

Interventions

OTHERPre & Post Surveys

As part of this intervention, patients will complete a pre-treatment questionnaire at the time of consent, which can be administered in person, over the phone, or through the mHealth mobile app, based on their preference. One month after treatment, patients will complete a post-treatment questionnaire using their chosen method. At the six-month mark, patients will complete an additional post-treatment questionnaire along with the COST-Functional Assessment of Chronic Illness Therapy (COST-FACT) survey.

OTHEROpt Out of Questionnaire

As part of this intervention, patients declined to participate in the optional questionnaire. However, their data will still be collected through chart review and will be compared to the data of patients who accepted both the questionnaire and navigation services.